Isracann Biosciences Pitch Deck
3
About isracann
Israel's First Pure-Play Cannabis Firm
Isracann, Israel's first pure-play cannabis firm, is focused on becoming a premier, low-cost
cannabis producer. Isracann has a joint venture agreement in place with a built 55,000 sq ft
farm, which is expandable to 160,000 sq ft in the near term and has access to over 2,000,000 sq
ft of private land. The company is targeting undersupplied domestic demand combined with an
immense international market opportunity through Israel's new medical cannabis export
framework for 2020.
Located in the cannabis research capital of the world, Isracann has relationships with the
research, scientific and medical community to identify opportunities and develop a pipeline of
drugs and devices.
The company is targeting an undersupplied domestic market and anticipates
near-term expansion to major European marketplaces.
isracann
BIOSCIENCESView entire presentation